A.M. Surgical
A.M. Surgical is a privately held medical device company that develops minimally invasive surgical instruments and biologic solutions — including the STRATOS carpal tunnel release systems and Allio meniscal allograft — for orthopedic, hand, trauma, and sports medicine surgeons in the United States.
- Company typePrivate
- Founded1995
- HeadquartersSmithtown, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What A.M. Surgical does
A.M. Surgical is a privately held, Nashua, New Hampshire–headquartered medical device company founded in 1995 by Dr. Ather Mirza and led since 2001 by Romi Mirza (Chairman). The company develops minimally invasive surgical devices and biologic solutions for hand, wrist, and small-joint procedures, organized into two categories. Its surgical device portfolio includes the STRATOS family of endoscopic carpal and cubital tunnel release systems (STRATOS Classic, STRATOS Retra Jr, STRATOS Ultra), the ENDOSLEEVE disposable scope-mounting knife for trigger finger release, the CPX non-spanning cross-pin fixator for distal radius fractures, and the SECURE IM Nail for hand fracture stabilization. Its biologic portfolio comprises the Allio pre-sculpted meniscal allograft for small joint resurfacing and the Mesos biologic solutions product line. Core technology centers on proprietary endoscopic visualization (notably a clear cannula providing 360° visibility and a dual-direction actuating blade) and a sterile, disposable all-in-one system architecture that eliminates capital equipment investment for hospitals. Leadership holds over 200 patents, underscoring the company's R&D depth.
The company's revenue model is hardware-driven: products are sold as sterile, disposable kits via direct field sales to orthopedic/hand surgeons, trauma surgeons, and sports medicine specialists at hospitals and surgical centers. Pricing is quote-based and not publicly disclosed. Go-to-market relies on dedicated sales representatives, participation in conferences such as ASSH, and an extensive surgeon training infrastructure that includes cadaver workshops, mobile training labs, and facilities in Las Vegas, Boston, and New York.
A.M. Surgical serves three primary surgeon personas — orthopedic/hand surgeons, trauma and emergency care surgeons, and sports medicine/joint specialists — across what is currently a U.S.-only footprint. The company remains family-led with no disclosed institutional investors, no M&A history, and 11–50 employees. Recent strategic emphasis is on extending the portfolio into biologics (Allio and Mesos) and building out the field sales organization to deepen surgeon adoption.
A.M. Surgical firmographics
Firmographics- Name
- A.M. Surgical
- Legal name
- A.M. Surgical, Inc.
- Website
- https://amsurgical.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- A.M. Surgical is a privately held medical device company that develops minimally invasive surgical instruments and biologic solutions — including the STRATOS carpal tunnel release systems and Allio meniscal allograft — for orthopedic, hand, trauma, and sports medicine surgeons in the United States.
- Ownership category
- akta.pro rank
Where A.M. Surgical is headquartered
LocationHeadquarters
- HQ city
- Smithtown
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
A.M. Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Medical Device Sales: Sale of proprietary surgical devices including the STRATOS CTR systems, ENDOSLEEVE, CPX fixators, and IM Nail systems. Products are sold as sterile, disposable all-in-one systems to surgeons and hospitals.
- Biologic Product Sales: Sale of biologic allograft products like ALLIO for small joint resurfacing and potential future Mesos biologic solutions for joint repair and tissue regeneration.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
A.M. Surgical product offering
Product offeringCore offering
A.M. Surgical develops, manufactures, and markets minimally invasive surgical devices and biologic solutions for hand, wrist, and small joint procedures. Its core offering is the STRATOS™ family of sterile, disposable, all-in-one endoscopic carpal and cubital tunnel release systems, complemented by fracture stabilization devices (CPX cross-pin fixator, SECURE IM Nail), the ENDOSLEEVE scope-mounting knife for trigger finger release, and biologic allograft products (Allio meniscal allograft, Mesos biologic line). Products are sold to orthopedic and hand surgeons and healthcare facilities through direct sales.
Product overview
A.M. Surgical develops high-precision devices for skeletal and soft tissue procedures with a focus on minimally invasive surgery. The product portfolio consists of two main categories: (1) Surgical device systems including the STRATOS™ family of carpal/cubital tunnel release systems (Classic, Retra Jr, Ultra), the SECURE IM Nail for hand fractures, the CPX fixator for distal radius fractures, and the ENDOSLEEVE for trigger finger release; and (2) Biologic solutions including the Allio meniscal allograft for small joint resurfacing and Mesos biologic solutions. The STRATOS systems share endoscopic technology compatible with standard arthroscopes and are offered as sterile disposable all-in-one systems.
Differentiator
Problem solved
Functional benefit
Brands
- Mesos: Biologic solutions product line
Products and services
- STRATOS™ Classic Flagship endoscopic Carpal Tunnel Release (CTR) system using a clear cannula that delivers 360-degree surgical field visualization to protect the median nerve during transverse carpal ligament release. It is a sterile, all-in-one disposable kit compatible with standard 4mm, 30° arthroscopes, sold to orthopedic/hand surgeons and healthcare facilities.
- STRATOS™ Retra® (Retra Jr™) High-performance, cost-effective endoscopic system for carpal and cubital tunnel releases featuring a dual-direction actuating blade capable of both retrograde and antegrade cuts, with a static cannula to prevent subluxation and clear cannula for superior visualization. Sterile, disposable, single-use system for surgeons and hospitals.
- STRATOS™ Ultra® Budget-friendly, minimalist CTR system with a streamlined functional design for carpal tunnel surgeries. Sterile, cost-effective disposable kit compatible with standard surgical equipment, sold to hand surgeons and surgical facilities.
- Allio Pre-Sculpted Meniscal Allograft Pre-sculpted meniscal allograft biologic implant for small joint resurfacing, designed for natural tissue integration and biocompatibility to support joint repair procedures and improved patient outcomes. Sold to sports medicine and joint reconstruction surgeons and healthcare facilities.
- SECURE IM Nail Intramedullary nail system for hand and metacarpal fracture stabilization that combines simplicity and efficiency using a time-tested approach for managing fractures. Sold to hand and orthopedic trauma surgeons in hospitals and surgical centers.
- CPX Non-Spanning Cross-Pin Fixator Non-spanning cross-pin fixator specifically designed for distal radius fracture treatment. Provides targeted stabilization through a minimally invasive approach that avoids extensive surgical intervention and supports enhanced recovery. Sold to trauma and orthopedic surgeons in hospitals.
- ENDOSLEEVE Scope-Mounting Knife System Disposable scope-mounting knife system that combines a scope and cutting mechanism into a single tool for surgical treatment of trigger finger via an endoscopic approach. Eliminates device maintenance and sterilization requirements while delivering clear visualization and precise cutting for hand surgeons.
- Mesos™ Biologic Solutions Biologic solutions product line positioned as 'The Future of Biologic Solutions' to complement A.M. Surgical's hardware portfolio, supporting joint repair and tissue regeneration use cases for sports medicine and joint reconstruction surgeons.
Quantifiable outcome
- Reduced recovery times compared to traditional open surgery
- +2 more outcomes
Companies that use A.M. Surgical
Customer profileSegments3 records
Ideal customer profiles3 records
A.M. Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
A.M. Surgical partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights4 records
A.M. Surgical competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
A.M. Surgical social profiles
Digital presenceA.M. Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
A.M. Surgical leadership team
Management profileNumber of profiles
Profiles4 records
A.M. Surgical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
A.M. Surgical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about A.M. Surgical
What does A.M. Surgical do?
A.M. Surgical develops, manufactures, and markets minimally invasive surgical devices and biologic solutions for hand, wrist, and small joint procedures. Its core offering is the STRATOS™ family of sterile, disposable, all-in-one endoscopic carpal and cubital tunnel release systems, complemented by fracture stabilization devices (CPX cross-pin fixator, SECURE IM Nail), the ENDOSLEEVE scope-mounting knife for trigger finger release, and biologic allograft products (Allio meniscal allograft, Mesos biologic line). Products are sold to orthopedic and hand surgeons and healthcare facilities through direct sales.
Is A.M. Surgical a public or private company?
A.M. Surgical is a private company. It is classified as family owned and is currently operating.
When was A.M. Surgical founded?
A.M. Surgical was founded in 1995. It employs 11 to 50 people.
Where is A.M. Surgical based?
A.M. Surgical is headquartered in Smithtown, United States, in the North America region.
How does A.M. Surgical make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are biologic Product Sales.
Does A.M. Surgical have an API?
No public API is recorded for A.M. Surgical.